618
www.neurologiepropraxi.cz34080430107651332012142633073553814284484965465656086586857327828098518919109269661005
/34768043010732
Neurol.3553804301075593139165209227243
praxi.3812804301074672114152170186
2024;25(1):53-564014804301074487128168183227271293333350365409451478521564
/46238043010732
NEUROLOGIE47018043010757101158205267310369428449493
PRO5216804301074591153
PRAXI5391804301074591147200221
5356558026012657114
PŘEHLEDOVÉ4549207012660124182256312369444520587645
ČLÁNKY5216207012660115187259327395
Ocrelizumab365336501063873109141173191223264318358394
–4063365010645
co412336501063372
víme,421036501063754108140157
co438236501063271
můžeme446936501065192124156211242
zlepšit47273650106316294129163180212
nyní495536501063976118135
a5106365010638
co515936501063372
v5246365010637
budoucnu529836501063475115156197232273314
Ocrelizumab3409320298172280371496563627739879108412101352
–17419320298120
co19099320298108244
víme,22029320298127191396522584
co28349320298108244
můžeme31279320298206344455580787913
zlepšit40889320298113180306449552617704
nyní48409320298141260401465
a34011920298127
co51511920298108244
v80811920298127
budoucnu984119202981432824255627018089481086
MUDr.3401590013793168245287311
Martin6731590013793152194236267332
Elišák,1027159001375990120168227286318
Ph.D.13671590013764128157235261
Neurologická3401744013372128188223283309369431456505555609
klinika972174401335279104164189240294
2.1289174401335679
LF13921744013352104
UK15201744013371130
a16731744013353
FN17501744013353123
Motol,18971744013388149184243269291
Praha2212174401335893146206258
Ocrelizumab,3402254012168114147197222245288344427475532552
jako912225401212472119173
monoklonální11042254012183138194250297323378434482506562585
protilátka1709225401215689144177201225273306353402
proti2131225401215689144178201
CD23512254012158124
2024942254012151101
lymfocytům,2614225401212472156185240286336373428511533
je3166225401212474
jedním3260225401212474132188211294
ze3574225401214292
zástupců3686225401214292340239401213973128185231285
vysoce644239401214899138194239288
účinné9512394012155100123178233284
léčby1254239401212374119176222
(HET1495239401212892142193
–17072394012150
high1776239401215578134189
efficacy1984239401215080113139184233278327
therapy).2330239401213388139172220277323350369
Změna27182394012155137188243291
paradigmatu30282394012157105138187243267323406454487542
léčby3588239401212474120176223
roztroušené340253401213388131168201257313353405461513
sklerózy878253401213987113164198254297348
z12512534012143
eskalační1319253401215090138188213262307364388
na17322534012155104
indukční1861253401212480138193241285342366
strategii2252253401213974108157191241299323347
(HET2624253401212994144197
jako2846253401212473121176
první3047253401215791143200224
léčba)3296253401212475122179229256
spolu3577253401213997154179234
s3402674012140
novými4002674012155112160211297321
indikačními741267401212480137162209259305361385470494
omezeními12552674012155140191236287343367452476
úhrady17512674012155112145195252301
vede2072267401214899157208
k23012674012146
rozšíření2368267401213388131173197234284341365
spektra2753267401214097150198235268318
pacientů,30912674012157107153177228284318374395
kterým3507267401214784134168219304
můžeme3402814012183139183234318370
tuto735281401213389123178
léčbu937281401212475122179236
nabídnout11972814012156105163187244301357413447
již166928140121244992
v17862814012148
počátku18592814012157114160210243291347
onemocnění.22312814012155111163247304350406458514538560
Více2816281401215679125175
studií3016281401213974130188212236
potvrdilo,32772814012157113147199233290315339395416
že3717281401214394
nasazení3402954012155104145195239290347371
HET7332954012165116168
v9232954012148
časných993295401214595135191237282338
fázích1353295401213080124148194250
nemoci16252954012156107192248294318
zlepšuje1966295401214267118176217272297348
u23362954012155
indikovaných2413295401212480138162209264312362418464509565
pacientů30002954012157107153177228285318374
prognózu3396295401215791146204260316359415
nejen3403094012155107132183240
potlačením6013094012157114148172221267317374398482
zánětlivé1105309401214293150201235260283333383
aktivity,1510309401214896132156206231265316333
ale1864309401214973124
i20103094012123
zpomalením20553094012143101158242292316367424448532
progrese.2609309401215791146204238289329380402
Zároveň30323094012156106139195243293349
však3403309401214889138186
stále3611309401213974124149200
existují340323401215098123163198254279303
otázky669323401215588138183231282
ohledně9773234012155111136187246302353
individuální1356323401212380137161211236293349398422478502
odpovědi18843234012155113171228276326384408
pacientů23183234012157107153177228285318374
na27183234012155104
tuto2848323401213389123178
terapii3052323401213383117167224249273
a33513234012148
možných34253234012183139183239286330386
zejména340337401214394119203254311360
dlouhodobých721337401215781137194250306364420478526571627
nežádoucích13693374012156107151202260316372418442488544
účincích.19343374012155101125181227251297353375
Cílem2330337401215882108159244
článku2595337401214569118174222278
je2895337401212475
poskytnout29913374012157114154202253291347403460494
pohled35063374012157114171195246305
na3403514012155103
stávající461351401213973122168217241264308332
znalosti,811351401214298146169224263297320341
aktuální1171351401214794130185232256311334
výzvy1524351401214798143194244
a17873514012147
budoucí18533514012156111167222277322345
perspektivy22173514012156107140180237288335370394442492
v27283514012147
používání27943514012156112167210233282330385408
ocrelizumabu.3221351401215499132182206229272327409457513568590
Klíčová340368001246189116160217268320
slova:676368001244370128179231256
roztroušená949368401213286127162193247301339389443490
skleróza,1456368401213985109159191244285334354
monoklonální18273684012183137191245292316370425472494548571
protilátky2415368401215688142174196219266297343392
proti2824368401215688142174196
CD30373684012158122
2031763684012151100
lymfocytům,3293368401212370152181234279328363417499519
ocrelizumab.3403824012155100133183207230272328411459516535
Ocrelizumab3404100012472118157210239267314374460514574
–9344100012450
what10054100012475135188225
we12504100012476128
know,13984100012455115173249272
what16904100012476135189225
we19364100012476128
can2084410001244599158
improve22624100012427114174213271323375
now,26574100012459117192216
what28934100012476135188225
we31394100012475128
can3287410001244599158
improve3404240012427114174213271323375
in735424001242887
the842424001243797150
future1012424001243493131190229282
Ocrelizumab,3404414012169115148198223246289345429477534554
as923441401214888
a10394414012149
monoclonal11174414012183139195251297320376432481504
antibody16504414012149104137160217274331379
against20584414012149105154177233272306
CD23934414012158124
2025464414012152102
lymphocytes,2677441401212471156214270326372422458508548569
is3275441401212463
one33674414012155111162
of3558441401215584
the3671441401213389140
representatives340455401213382139172221261311366398447479502550599638
of996455401215584
high1098455401215578134189
efficacy1304455401215080112138183231276325
therapy1647455401213388138171219276322
(HET).1986455401212992142193224242
The22464554012150106156
paradigm24204554012156105137185242265321403
shift2841455401214095118147183
in3042455401212378
the3138455401213388138
treatment3294455401213365115162195278328383415
of3727455401215584
multiple3404694012182136158190213268291340
sclerosis697469401213983105155187240278300338
from1052469401212961115197
an12654694012148102
escalation1384469401214987131179202248280302356410
to1811469401213386
an19134694012148102
induction2032469401212377132186229264286340394
strategy2443469401213972104151182231286333
(HET2793469401212790138189
as2999469401214785
first-line310146940121295485125158185209231285334
therapy),3452469401213387136168215270316341359
together340483401213387143193227281332364
with722483401217397130185
new9244834012156106179
indication1121483401212378134157202250283305360416
restrictions1554483401213383122155188211256291314369424463
on20354834012154110
reimbursement,2162483401213383106189245300333373423506557612644665
has28454834012155103142
led3004483401212474131
to3153483401213387
a32574834012148
broadening3323483401215790144193249299354377432488
of340497401215584
the446497401213389139
spectrum607497401214096147193228261316400
of1029497401215584
patients11354974012157106138161211267299340
to1497497401213387
whom16074974012173129184268
we18974974012174123
can2042497401214594149
offer2213497401215584117167200
this2435497401213489112151
treatment2608497401213366116164196279330386418
early3048497401215098131155202
in3272497401212479
the3373497401213388139
course3534497401214599154186227277
of340511401215584
the442511401213388138
disease.598511401215679118168216255305325
Multiple9415114012180135158191214270294344
studies1303511401214073128185208258297
have16185114012155103149198
confirmed1834511401214598154182209241324375432
that2283511401213388136169
the2469511401213388139
use2625511401215594145
of2787511401215584
HET28895114012165114166
in3072511401212479
the3168511401213488139
early3324511401215098131154202
stages3543511401214074122178228267
of340525401215584
the445525401213489139
disease606525401215679118169217256306
improves9345254012123106163196251298347386
the1342525401213388138
prognosis1502525401215790144201256311351374413
of1936525401215584
indicated2042525401212378135158203251284333390
patients24545254012157106138161211267299340
not28155254012156111144
only29805254012155111134182
by31835254012157103
suppressing3308525401213994151208241290330369392447503
inflammatory340539401212379108134182265348396429483516566
activity933539401214993129152200224257307
but12675394012157112145
also1440539401214871110166
by16335394012157103
slowing1763539401214063118191215270326
progression.2116539401215790145202234284323362385440496517
At2660539401216293
the2780539401213388139
same2946539401214089172222
time,3196539401213356139189209
however,34335394012155110183233280329362378
there340553401213388139172221
are580553401214881131
still72955340121407497120143
questions8915534012156111161201235258313368407
about13175534012148105161216249
the1585553401213388139
individual1742553401212479136159207231287342390414
response2174553401213383122179235290329380
of2573553401215584
patients26755534012157106138162212267300340
to3034553401213387
this3140553401213388111150
therapy3309553401213388139172220277323
and36515534012148103160
the340567401213388139
possible5035674012157113152191214271295345
long-term873567401212378134190222255305337421
side1319567401213962119169
effects1512567401215080113163209244285
in1821567401212379
particular.19245674012157106138174197242297320368400417
The23655674012150106157
aim2546567401214872155
of2725567401215584
this2833567401213489112151
article3008567401214881117140185208258
is3291567401212362
to3377567401213488
provide3489567401215790144192215272322
an3405814012148103
insight463581401212379118140196252284
into766581401212479111165
the951581401213388139
current11095814012145100132165215271303
knowledge,14325814012146103158231255306363419469489
current1941581401214599132165215270303
challenges22635814012145100148172195245301357407447
and27295814012148104160
future2909581401212985118173205255
perspectives31845814012156108140181237288334369392441490529
in3733581401212378
the340595401213388139
use500595401215594145
of666595401215584
ocrelizumab.7715954012155101133183207230273328411459516536
Key3406120012461113164
words:5316120012476134172232277303
multiple8626124012183138162195218274298349
sclerosis,1239612401213985108158191246285308347368
monoclonal16356124012184139194250295318374429477501
antibodies21646124012148103136159215271328352402441
against26346124012148104152175230269303
CD29656124012158124
2031176124012151102
lymphocytes,3247612401212371155212268323368418454504543564
ocrelizumab.3406264012155100133183207230272328411459516535
Co3406750014771137
víme504675001476193195258
nyní7896750014769127197228
Zařazení480692101095198129176217265318341
ocrelizumabu853692101095094125173197219260313391437491544
mezi14286921010978126167191
HET16516921010960107156
bylo1839692101095397121174
potvrzeno3407061010951102132178208249294344394
již75670610109224382
v8607061010943
roce924706101093079121165
2017.1111706101094692134174184
Ve1317706101095093
studiích1431706101093667116168189210251301
OPERA17537061010962111154202260
I/II34072010109225680104
prokázal480720101095385137183230272320343
vyšší859720101094593132169192
potlačení10887201010952106138161207250297351374
zánětlivé1498720101093987140189221244267314361
aktivity189572010109459034073410109305298120151198
i5657341010921
progrese613734101095283134187217264301348
oproti9887341010950104135186217238
interferonu1253734101092273104150181211258289340392443
beta-1a17227341010953100132178208250290
(Hauser340748101092684128178214260290
et655748101094676
al.,75774810109436584104
2017).886748101094792135175201218
Po1130748101094896
aplikaci1252748101094395117138181226266288
ocrelizumabu15657481010950911211661882102492993744183407621010951101
dochází4607621010951101143192236275297
k7767621010942
rychlé837762101093075115165186232
depleci1088762101095197148170216257279
CD13867621010952111
201516762101094692
lymfocytů1627762101092164140167217258303336386
v3407761010943
periferní409776101095198128150177223253304325
krvi760776101094273120142
s9277761010936
detekovatelným989776101095197127172215264307352381426449499540617
počátkem16317761010952103144189218261306381
v21406781010944
řádu2211678101093075128179
několika2416678101095198142192215237280326
hodin27696781010950102155177228
a30246781010944
k30956781010943
plné3164678101095275127174
depleci3364678101095299152175222264286
dochází367767810109521032140692101094191136176198
u23646921010950
většiny2440692101094489120157179230272
pacientů2738692101095297138159206257287338
již310269210109224383
ve3211692101094489
čtvrtém3326692101094173120151184230306
dnu36586921010952103153
(Barkof2140706101092674118148191239266
et2422706101094576
al.,251470610109436584103
2019).2633706101094792135176200217
To2866706101094589
se2971706101093682
projevuje3069706101095181131152198241292313359
v34447061010944
rychlém3504706101092975115165186232307
potlačení21407201010951101130151193233277327347
zánětlivé2503720101093882132177206227248291335
aktivity2853720101094385117137181202231276
–31447201010945
klinické320472010109426485134155195236280
do3500720101095099
osmi,3614720101094984158179198
rezonanční2140734101092975114164214258308349399420
do25767341010951101
čtyř2694734101094072117147
týdnů2858734101093075125176225
(Barkof3100734101092574118148190239266
et3382734101094576
al.,347473410109446584104
2019).3594734101094792135176200217
Dlouhodobou2140748101096083133183234284336386438489540
účinnost2705748101095091112162213263299330
ocelizumabu3061748101094991135158179218268344388439490
potvrzují357674810109521031331792102140762101093988110131
devítiletá2295762101095197140162192213234280310355
sledování2673762101093657103155205248292342363
otevřené3059762101095080125168198243294339
fáze3422762101092671110155
studií3601762101093667116168189210
OPERA21407761010964114159209268
I/II243477610109225578101
–25627761010946
z26357761010939
pacientů,2701776101095298140162210262292344364
kteří3092776101094377123154176
zahájili3295776101094086138183206228251273
léčbu3594776101092269112165217
DECLARATIONS:4068227708648871301662142563043393604124625014570227808514
Declaration406824140874987120141179207245272292334376
of445824140874166
originality:45382414087406888131151193231252272299338358
The406825260853473109
manuscript418825260855791130168195227249266306329
is452825260851644
original45832526085386178117133172205222
and481625260853472112
has49392526085387299
not50502526085387699
been516125260853975110149
published532125260854078118135151178217252292
or406826360853862
submitted414526360852867108167184208234269310
elsewhere.44702636085355381117169209246269305320
Ethics406827720873764107127160192
approval427427720873780124151193230268289
and457727720873779122
consent471327720873273115147185228254
to498127720872668
participate:506327720874280108136156189210253291318356375
The406828850853575111
authors41992885085347397137176200229
attest44482885085345883119147172
that46402885085236297120
their47802885085236399116140
study49402885085285292132166
is512628850851745
in519128850851656
compliance526628850853270130170188205239279312347
with40682995085526993133
human421629950853978138172212
studies44442995085275291132149185214
committees467429950853169129188205229255290327355
and504529950853474114
animal51752995085347390149184201
welfare539229950855287105126162185221
regulations406831050852461103144163199224242283325354
of444531050854062
the453031050852465103
authors’465631050853575101142183209239255
institutions49343105085175888114132157199224242283325355
as531131050853565
well539931050855390109127
as554931050853464
with40683215085526993133
the42213215085236299
Food433932150853573113154
and451332150853473114
Drug464732150854771110151
Administration481732150854383143160199217245270293328352369409449
guidelines,52853215085397996137173190208247283312328
including40683325085175791108149190208249290
patient437933250854076101119156197221
consent462133250853271112141179219244
where488533250855394131156193
appropriate.509833250853577119143183225250268304328365380
The549933250853577114
authors40683435085347397136176200229
also43093435085345179119
declare444134350853975108125159183219
that46723435085236397121
their48063435085236298116139
paper495834350854074115152175
is514634350851645
in520334350851756
accordance52723435085336697135159200234274306341
with40683545085527095135
the422335450852464101
World434435450856099123141183
Medical454735450855794136154186222240
Association480735450854474103143176194229253271311351
Declaration517935450854784118135171195230254272312353
of555235450853961
Helsinki406836550854684102131148189223242
on433036550853980
Ethical443036550853560100118151187204
Principles46553655085386179120153170212230267296
for49723655085206185
Medical507836550855794136154187222240
Research533936550853875104141176201233274
Involving40683765085175689127145179196236275
Human435637650854584143177216
Subjects458537650853473113130166198224253
adopted485037650853374113153177212253
by511537650853973
the52003765085236298
18th53103765085366993132
WMA5454376508559115159
General406838750854582122158182217234
Assembly431938750854373101137197237255289
in462538750851756
Helsinki,469838750854683100128145185219237252
Finland,49673875085345191108142182222238
in522238750851756
June529538750852666105142
1964,545438750853669106144159
with40683985085527095135
subsequent422439850852867109138175217257294334358
amendments,460339850853494131172213273310351375405421
as504539850853463
well512839850855389107125
as527339850853463
with53573985085527094135
the551239850852464101
ICMJE406840950851758114141176
Recommendations425640950853772104142201259294334373407430447485525552
for48204095085205982
the49144095085236297
Conduct,502340950854078117157196227252267
Reporting,530240950853873113152176201218256296311
Editing,40684205085347491115132172212227
and430842050853373113
Publication443442050853776117134151183218242259298338
of478542050853859
Scholarly485742050853467106146163198221239273
Work514342050855996120154
in531042050851656
Medical537842050855693134151183218235
Journals,406843150852666105129169203221249265
updated434743150853980121155179214255
in461743150851656
December468843150854683116151210251288311
2018.501443150853672106140156
Conflict406844510874282125150171191224252
of433444510874066
interest:44144451087196188126154192224251271
Not406845630854686110
applicable.419345630853374115132149182217257275311326
Consent406846990874282125156194237263
for43464699087236593
publication:445346990874284127148168201239266287329371390
Not406848110854686110
applicable.419348110853374115132149182217257275311326
Authors’406849470874687114157199226258278
contributions:436049470873273115142170190233275303323365407439458
A/N406850600854370117
Cit.4068714508541588298
zkr:41807145085306489105
Neurol.429971440864680120145184203221
praxi.453271440863964102137156173
2024;25(1):53-56472071440863876113150168206244265300318334373410433471509
https://doi.org/10.36290/neu.2024.008406872550853962881291571721982194284725408641811004385725508514547811714345277254086387390130168206244283306346383424442482520558595613651691730
Článek40687365085415892132168202
přijat4285736508539638198133156
redakcí:445673650852359100134168199216231
5.470273650853550
12.47677365085366884
2023486573650853672107144
Článek40687475085415892132168202
přijat4285747508539638198133156
k4456747508533
publikaci:450474750854079120138155188223256273287
30.48067475085367288
1.490874750853649
2024497174750853672107142
MUDr.4068766708759108158186202
Martin428576670875997125153174216
Elišák,45157667087385979111149188209
Ph.D.473876670874183102153171
martin.elisak@fnmotol.cz406877800855893117143160199215251268285314349382435457497556596620658676692724756